Search Results

There are 19513 results for: content related to: Adverse childhood experiences of persons at risk for Huntington's disease or BRCA1/2 hereditary breast/ovarian cancer

  1. You have full text access to this Open Access content
    Secondary mutations of BRCA1/2 and drug resistance

    Cancer Science

    Volume 102, Issue 4, April 2011, Pages: 663–669, Kiranjit K. Dhillon, Elizabeth M. Swisher and Toshiyasu Taniguchi

    Version of Record online : 30 JAN 2011, DOI: 10.1111/j.1349-7006.2010.01840.x

  2. Skin cancer risk in BRCA1/2 mutation carriers

    British Journal of Dermatology

    Volume 172, Issue 6, June 2015, Pages: 1498–1506, P.V. Gumaste, L.A. Penn, R.M. Cymerman, T. Kirchhoff, D. Polsky and B. McLellan

    Version of Record online : 29 APR 2015, DOI: 10.1111/bjd.13626

  3. You have free access to this content
    Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel

    Cancer

    Volume 121, Issue 1, January 1, 2015, Pages: 25–33, Nadine Tung, Chiara Battelli, Brian Allen, Rajesh Kaldate, Satish Bhatnagar, Karla Bowles, Kirsten Timms, Judy E. Garber, Christina Herold, Leif Ellisen, Jill Krejdovsky, Kim DeLeonardis, Kristin Sedgwick, Kathleen Soltis, Benjamin Roa, Richard J. Wenstrup and Anne-Renee Hartman

    Version of Record online : 3 SEP 2014, DOI: 10.1002/cncr.29010

  4. You have free access to this content
    The molecular pathogenesis of hereditary ovarian carcinoma

    Cancer

    Volume 116, Issue 22, 15 November 2010, Pages: 5261–5271, Barbara M. Norquist, Rochelle L. Garcia, Kimberly H. Allison, Chris H. Jokinen, Lauren E. Kernochan, Catherine C. Pizzi, Bethany J. Barrow, Barbara A. Goff and Elizabeth M. Swisher

    Version of Record online : 3 NOV 2010, DOI: 10.1002/cncr.25439

  5. All in the family: Evaluation of the process and content of sisters' communication about BRCA1 and BRCA2 genetic test results

    American Journal of Medical Genetics

    Volume 107, Issue 2, 15 January 2002, Pages: 143–150, Chanita Hughes, Caryn Lerman, Marc Schwartz, Beth N. Peshkin, Lari Wenzel, Steven Narod, Camille Corio, Kenneth P. Tercyak, Danielle Hanna, Claudine Isaacs and David Main

    Version of Record online : 28 NOV 2001, DOI: 10.1002/ajmg.10110

  6. BRCA1/2 testing: uptake, phenocopies, and strategies to improve detection rates in initially negative families

    Clinical Genetics

    Volume 82, Issue 5, November 2012, Pages: 478–483, C Fischer, C Engel, C Sutter, S Zachariae, R Schmutzler, A Meindl, S Heidemann, T Grimm, TO Goecke, I Debatin, D Horn, P Wieacker, D Gadzicki, K Becker, D Schäfer, F Stock, T Voigtländer and on behalf of the German Consortium for Hereditary Breast and Ovarian Cancer

    Version of Record online : 19 OCT 2011, DOI: 10.1111/j.1399-0004.2011.01788.x

  7. Single-nucleotide polymorphisms in the p53 pathway genes modify cancer risk in BRCA1 and BRCA2 carriers of Jewish-Ashkenazi descent

    Molecular Carcinogenesis

    Volume 49, Issue 6, June 2010, Pages: 545–555, Ronit I. Yarden, Eitan Friedman, Sally Metsuyanim, Tzvia Olender, Edna Ben-Asher and Moshe Z. Papa

    Version of Record online : 19 MAR 2010, DOI: 10.1002/mc.20618

  8. You have free access to this content
    MicroRNA expression signatures for the prediction of BRCA1/2 mutation-associated hereditary breast cancer in paraffin-embedded formalin-fixed breast tumors

    International Journal of Cancer

    Volume 136, Issue 3, 1 February 2015, Pages: 593–602, Miljana Tanic, Kira Yanowski, Gonzalo Gómez-López, María Socorro Rodriguez-Pinilla, Iván Marquez-Rodas, Ana Osorio, David G. Pisano, Beatriz Martinez-Delgado and Javier Benítez

    Version of Record online : 19 JUN 2014, DOI: 10.1002/ijc.29021

  9. You have full text access to this Open Access content
    BRCA1/2 mutation analysis in 41 ovarian cell lines reveals only one functionally deleterious BRCA1 mutation

    Molecular Oncology

    Volume 7, Issue 3, June 2013, Pages: 567–579, Britta Stordal, Kirsten Timms, Angela Farrelly, Danielle Gallagher, Steven Busschots, Mickaël Renaud, Julien Thery, Deborah Williams, Jennifer Potter, Thanh Tran, Greg Korpanty, Mattia Cremona, Mark Carey, Jie Li, Yang Li, Ozlem Aslan, John J. O'Leary, Gordon B. Mills, Bryan T. Hennessy

    Version of Record online : 31 JAN 2013, DOI: 10.1016/j.molonc.2012.12.007

  10. Young adult daughters of BRCA1/2 positive mothers: What do they know about hereditary cancer and how much do they worry?

    Psycho-Oncology

    Volume 22, Issue 9, September 2013, Pages: 2024–2031, Andrea F. Patenaude, Nadine Tung, Paula D. Ryan, Leif W. Ellisen, Larissa Hewitt, Katherine A. Schneider, Kenneth P. Tercyak, Julie Aldridge and Judy E. Garber

    Version of Record online : 18 FEB 2013, DOI: 10.1002/pon.3257

  11. You have free access to this content
    BRCA1 and BRCA2 germline mutations are frequently demonstrated in both high-risk pancreatic cancer screening and pancreatic cancer cohorts

    Cancer

    Volume 120, Issue 13, 1 July 2014, Pages: 1960–1967, Aimee L. Lucas, Laura E. Frado, Caroline Hwang, Sheila Kumar, Lauren G. Khanna, Elana J. Levinson, John A. Chabot, Wendy K. Chung and Harold Frucht

    Version of Record online : 15 APR 2014, DOI: 10.1002/cncr.28662

  12. You have free access to this content
    Comparison of age at natural menopause in BRCA1/2 mutation carriers with a non–clinic-based sample of women in northern California

    Cancer

    Volume 119, Issue 9, 1 May 2013, Pages: 1652–1659, Wayne T. Lin, Mary Beattie, Lee-may Chen, Kutluk Oktay, Sybil L. Crawford, Ellen B. Gold, Marcelle Cedars and Mitchell Rosen

    Version of Record online : 29 JAN 2013, DOI: 10.1002/cncr.27952

  13. Impact of a paternal origin of germline BRCA1/2 mutations on the age at breast and ovarian cancer diagnosis in a Southern Swedish cohort

    Genes, Chromosomes and Cancer

    Volume 54, Issue 1, January 2015, Pages: 39–50, Carolina Ellberg, Helena Jernström, Per Broberg, Åke Borg and Håkan Olsson

    Version of Record online : 23 SEP 2014, DOI: 10.1002/gcc.22217

  14. Which factors predict proposal and uptake of psychological counselling after BRCA1/2 test result disclosure?

    Psycho-Oncology

    Volume 23, Issue 4, April 2014, Pages: 420–427, Christine Maheu, Anne-Deborah Bouhnik, Catherine Nogues, Emmanuelle Mouret-Fourme, Dominique Stoppa-Lyonnet, Christine Lasset, Pascaline Berthet, Jean-Pierre Fricker, Olivier Caron, Elizabeth Luporsi, Laurence Gladieff and Claire Julian-Reynier

    Version of Record online : 11 OCT 2013, DOI: 10.1002/pon.3435

  15. BRCA1/2-negative hereditary triple-negative breast cancers exhibit BRCAness

    International Journal of Cancer

    Volume 140, Issue 7, 1 April 2017, Pages: 1545–1550, Pawel Domagala, Jolanta Hybiak, Cezary Cybulski and Jan Lubinski

    Version of Record online : 24 JAN 2017, DOI: 10.1002/ijc.30570

  16. You have free access to this content
    When parents disclose BRCA1/2 test results: Their communication and perceptions of offspring response

    Cancer

    Volume 118, Issue 13, 1 July 2012, Pages: 3417–3425, Angela R. Bradbury, Linda Patrick-Miller, Brian L. Egleston, Olufunmilayo I. Olopade, Mary B. Daly, Cynthia W. Moore, Colleen B. Sands, Helen Schmidheiser, Preethi K. Kondamudi, Maia Feigon, Comfort N. Ibe and Christopher K. Daugherty

    Version of Record online : 9 JAN 2012, DOI: 10.1002/cncr.26471

  17. Clinico–pathological characteristics of BRCA1- and BRCA2-related breast cancer

    Seminars in Surgical Oncology

    Volume 18, Issue 4, June 2000, Pages: 287–295, Pierre O. Chappuis, Victoria Nethercot and William D. Foulkes

    Version of Record online : 4 MAY 2000, DOI: 10.1002/(SICI)1098-2388(200006)18:4<287::AID-SSU3>3.0.CO;2-5

  18. You have free access to this content
    The phases of disclosing BRCA1/2 genetic information to offspring

    Psycho-Oncology

    Volume 17, Issue 8, August 2008, Pages: 797–803, Susan Clarke, Kate Butler and Mary Jane Esplen

    Version of Record online : 22 JUL 2008, DOI: 10.1002/pon.1344

  19. You have free access to this content
    Improved overall survival after contralateral risk-reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer: A prospective analysis

    International Journal of Cancer

    Volume 136, Issue 3, 1 February 2015, Pages: 668–677, Bernadette A.M. Heemskerk-Gerritsen, Matti A. Rookus, Cora M. Aalfs, Margreet G.E.M. Ausems, Johanna M. Collée, Liesbeth Jansen, C. Marleen Kets, Kristien B.M.I. Keymeulen, Linetta B. Koppert, Hanne E.J. Meijers-Heijboer, Thea M. Mooij, Rob A.E.M. Tollenaar, Hans F.A. Vasen, HEBON, Maartje J. Hooning and Caroline Seynaeve

    Version of Record online : 8 JUL 2014, DOI: 10.1002/ijc.29032

  20. You have free access to this content
    Are physician recommendations for BRCA1/2 testing in patients with breast cancer appropriate? A population-based study

    Cancer

    Volume 119, Issue 20, 15 October 2013, Pages: 3596–3603, Anne Marie McCarthy, Mirar Bristol, Tracey Fredricks, Lache Wilkins, Irene Roelfsema, Kaijun Liao, Judy A. Shea, Peter Groeneveld, Susan M. Domchek and Katrina Armstrong

    Version of Record online : 16 JUL 2013, DOI: 10.1002/cncr.28268